Legal & General Group
VNRX icon

Legal & General Group’s VolitionRx Ltd VNRX Stock Holding History

Legal & General Group’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-143
Closed -$11K – 3654
2021
Q1 		$11K Hold
143
– – ﹤0.01% 3356
2020
Q4 		$11K Hold
143
– – ﹤0.01% 3316
2020
Q3 		$9K Sell
143
-47
-25% -$3.19K ﹤0.01% 3274
2020
Q2 		$15K Buy
+190
New +$13.7K ﹤0.01% 3193

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legal & General Group's VNRX Position: Q2 2021 in Review

Legal & General Group sold out of VolitionRx Ltd (VNRX) in Q2 2021, closing a stake of 143 shares — an estimated $11K sold.

Legal & General Group first reported a position in VNRX in Q2 2020 and held it in 4 quarters. The position peaked at $15K in Q2 2020. 46 funds tracked by Wall St. Rank hold VNRX as of Q2 2021.

  • Legal & General Group reported no remaining VolitionRx Ltd position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 143 VolitionRx Ltd shares in Q2 2021, an estimated $11K.
  • Legal & General Group first reported a position in VolitionRx Ltd in Q2 2020 and held it in 4 quarters.
  • Legal & General Group's VolitionRx Ltd position peaked at $15K in Q2 2020.
  • 46 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.